TY - JOUR T1 - Real world validation of activity recognition algorithm and development of novel behavioral biomarkers of falls in aged control and movement disorder patients JF - medRxiv DO - 10.1101/2022.11.23.22282685 SP - 2022.11.23.22282685 AU - Ali Nouriani AU - Alec Jonason AU - Luke Sabal AU - Jacob Hanson AU - James Jean AU - Thomas Lisko AU - Emma Reid AU - Yeng Moua AU - Shane Rozeboom AU - Kaiser Neverman AU - Casey Stowe AU - Rajesh Rajamani AU - Robert A. McGovern Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/11/28/2022.11.23.22282685.abstract N2 - The use of wearable sensors in movement disorder patients such as Parkinson’s disease (PD) and normal pressure hydrocephalus (NPH) is becoming more widespread, but most studies are limited to characterizing general aspects of mobility using smartphones. There is a need to accurately identify specific activities at home in order to properly evaluate gait and balance at home, where most falls occur.We developed an activity recognition algorithm to classify multiple daily living activities including high fall risk activities such as sit to stand transfers, turns and near-falls using data from 5 inertial sensors placed on the chest, upper-legs and lower-legs of the subjects. The algorithm is then verified with ground truth by collecting video footage of our patients wearing the sensors at home.Our activity recognition algorithm showed >95% sensitivity in detection of activities. Extracted features from our home monitoring system showed significantly better correlation (∼69%) with prospectively measured fall frequency of our subjects compared to the standard clinical tests (∼30%) or other quantitative gait metrics used in past studies when attempting to predict future falls over one year of prospective follow-up.Although detecting near-falls at home is difficult, our proposed model suggests that near-fall frequency is the most predictive criterion in fall detection through correlation analysis and fitting regression models.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded in part by a grant from the University of Minnesota MnDRIVE and Neuromodulation Program and Institute for Engineering in Medicine (IEM) doctoral fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Minnesota and Minneapolis VA IRBs gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors ER -